| Literature DB >> 33633940 |
Jilei Lin1, Xingping Tao2, Wanmin Xia3, Jing Liu4, Lin Zhong5, Xin Sun6, Lu Liu7, Lei Li8, Rong Jin9, Li Cheng10, Zhongtao Wang11, Zhengxiu Luo1, Qubei Li1, Enmei Liu1, Zhou Fu1, Jihong Dai1.
Abstract
BACKGROUND: This study aims to investigate the current use of pediatric flexible bronchoscopy (PFB) in western China.Entities:
Keywords: Flexible bronchoscopy; survey; western China
Year: 2021 PMID: 33633940 PMCID: PMC7882290 DOI: 10.21037/tp-20-244
Source DB: PubMed Journal: Transl Pediatr ISSN: 2224-4336
Figure 1The included provinces of this study.
Characteristics of team members of bronchoscopy in centers
| Variable | Outcome |
|---|---|
| Team members of bronchoscopy | |
| Number of physicians, number (not available/available, median, range) | 0 (0%)/47 (100%), 5, 1–20 |
| Number of nurses, number (not available/available, median, range) | 0 (0%)/47 (100%), 4, 1–19 |
| Number of anesthesiologists, number (not available/available, median, range) | 23 (48.9%)/24 (51.1%), 1, 0–5 |
| Physicians in the team | |
| Proportion of physicians having received professional training (median, range) | 50%, 0–100% |
| Highest position, number | Chief physician, 31 (66.0%); associate chief doctor, 13 (27.7%); attending physician, 3 (6.4%) |
| Lowest position, number | Associate chief doctor, 2 (4.3%); attending physician, 26 (55.3%); residents, 19 (40.4%) |
| Highest educational degree, number | Doctorate, 9 (19.1%); master, 27 (57.4%); bachelor, 11 (23.4%) |
| Lowest educational degree, number | Master, 3 (6.4%); bachelor, 41 (87.2%); associates, 3 (6.4%) |
| Members in the bronchoscopy procedure | |
| Physicians, number (not available/available, median, range) | 0 (0%)/47 (100%), 2, 1–6 |
| Nurses, number (not available/available, median, range) | 0 (0%)/47 (100%), 2, 1–6 |
| Anesthesiologists, number (not available/available, median, range) | 23 (48.9%)/24 (51.1%), 1, 0–2 |
| Other members, number (not available/available, median, range) | 34 (72.3%)/13 (27.7%), 0, 0–3 |
Indication of flexible bronchoscopy and meta-analysis for proportion of disease
| Indication of flexible bronchoscopy | Median | Range | Pooled proportion with 95% CI | I2 |
|---|---|---|---|---|
| Persistent/recurrent wheeze | 27 | 0–503 | 0.18 (0.17–0.2) | 81% |
| Stridor | 5 | 0–105 | 0.02 (0.01–0.03) | 93% |
| Chronic cough | 18 | 0–700 | 0.13 (0.11–0.15) | 93% |
| Persistent/recurrent pneumonia | 10 | 0–200 | 0.07 (0.06–0.09) | 91% |
| Atelectasis/lobar pneumonia | 33 | 0–1,000 | 0.26 (0.25–0.3) | 95% |
| Pulmonary nodule | 1 | 0–70 | 0.006 (0.004–0.008) | 80% |
| Interstitial pneumonia | 4 | 0–100 | 0.024 (0.018–0.03) | 91% |
| Hemoptysis | 2 | 0–100 | 0.014 (0.011–0.018) | 77% |
| Tuberculosis | 3 | 0–193 | 0.01 (0.008–0.02) | 89% |
| Suspected lung malformation | 8 | 0–500 | 0.05 (0.04–0.07) | 96% |
| Foreign body | 9 | 0–100 | 0.02 (0.01–0.03) | 84% |
| Other indication | 6 | 0–249 | 0.04 (0.02–0.05) | 97% |
Median: the median number of participant in centers; pooled proportion performed by random effect model; I2 is for statistical heterogeneity.
The adverse events during and after flexible bronchoscopy
| The adverse events | Not occurred | Occurred | Pooled proportion with 95% CI | I2 |
|---|---|---|---|---|
| During flexible bronchoscopy | ||||
| Bleeding | 10 (21.3%) | 37 (78.7%) | 0.02 (0.013–0.027) | 85% |
| Bronchospasm | 26 (55.3%) | 21 (44.7%) | 0.001 (0.000–0.002) | 83% |
| Laryngospasm | 24 (55.1%) | 23 (44.9%) | 0.003 (0.002–0.005) | 80% |
| Hypoxia or decreased O2 saturation | 7 (14.9%) | 40 (85.1%) | 0.04 (0.03–0.6) | 97% |
| Reactions to drugs | 43 (91.5%) | 4 (8.5%) | – | – |
| Arrhythmia | 45 (95.7%) | 2 (4.3%) | – | – |
| Pneumothorax or submediastinal emphysema | 45 (95.7%) | 2 (4.3%) | – | – |
| Death | 47 (100%) | 0 (0%) | – | – |
| Other adverse events | 46 (97.9%) | 1 (2.1%) | – | – |
| After flexible bronchoscopy | ||||
| Bronchospasm | 33 (70.2%) | 14 (29.8%) | 0.001 (0.000–0.002) | 81% |
| Laryngeal edema | 21 (44.7%) | 26 (55.3%) | 0.006 (0.004–0.008) | 79% |
| Obvious cough | 1 (2.1%) | 46 (97.9%) | 0.24 (0.18–0.29) | 99% |
| Fever | 7 (14.9%) | 40 (85.1%) | 0.04 (0.03–0.05) | 94% |
| Hoarseness | 20 (42.6%) | 27 (57.4%) | 0.007 (0.005–0.009) | 79% |
| Death | 47 (100%) | 0 (0%) | – | – |
| Other adverse events | 46 (97.9%) | 1 (2.1%) | – | – |
Pooled proportion performed by random effect model; I2 is for statistical heterogeneity, – is due to the limited data for meta-analysis.
Figure 2Hierarchical cluster analysis of these included cities.